Viking Global Investors LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Viking Global Investors LP
CRD #132272
SEC #801-72433
CIK #0001103804
AUM $69.8 B (2025-07-31)
Employees 268 (28% Investors, 0% Brokers)
Phone203-863-5000
Address600 Washington Boulevard
Stamford, CT 06901-6000
Source [IAPD] [EDGAR] [Website] [LinkedIn]
Total AUM ($B)
705642281402011201620212026
Sector Form 13F Holdings Value ($B)
Bank of America Corp /DE/ 1.5
Schwab Charles Corp 1.4
Capital One Financial Corp 1.2
J P Morgan Chase & Co 1.2
US Bancorp de 1.1
Taiwan Semiconductor Manufacturing Co Ltd 1.0
McDonalds Corp 0.9
Amazon Com Inc 0.9
Fortive Corp 0.8
Bridgebio Pharma Inc 0.8
View All
Holdings by Sector ($B)
40322416802012201620212026
Type Form D Funds Date Sold ($M) AUM ($M)
PE Viking Structured Capital Offshore 2 Intermediate LP 2024-03-28 158.4
PE Viking Structured Capital Offshore LP [2023-03-31] 170.5 97.9
PE Viking Structured Capital Onshore LP [2023-03-31] 165.0 326.9
PE Viking Structured Capital Sidecar Offshore 2 LP 2023-03-31 140.8
PE Viking Structured Capital Sidecar Offshore LP [2023-03-31] 120.0 122.8
PE Viking Structured Capital Sidecar Onshore LP [2023-03-31] 10.0 10.2
PE Viking Global Opportunities Drawdown Offshore LP [2022-03-31] 0.0 707.4
PE Viking Global Opportunities Drawdown Onshore LP [2022-03-31] 0.0 1,190.8
HF Viking Global Equities Master Ltd [2019-03-29] 4,189.2 40,652.5
HF Viking Global Opportunities Master LP [2015-03-27] 2,378.9 16,845.2
View All
AUM Breakdown Accounts AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 21 69.8
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 21 69.8
By Discretionary
Discretionary 21 69.8
Non-Discretionary 0 0.0
Total 21 69.8
By Non-United States Persons
Non-United States Persons 46.9
United States Persons 22.9
Total 21 69.8
Limited Partners2011 - 2025
Houston Police Officers' Pension System
New York State and Local Retirement System
Form D Directors # Filings # Firms 2011 - 2025
Daniel Sundheim 38
Thomas Purcell 21
David Ott 19
O Halvorsen 19
Viking Global Investors LP 19
Rose Shabet 18
Viking Global Performance LLC 7
Viking Structured Capital GP LLC 5
Viking Global Opportunities Drawdown GP LLC 3
Viking Long Fund GP LLC 3
View All
EDGAR Form CIK 2011 - 2025
13F-HR [0001103804]
3 [0001103804]
4 [0001103804]
SC 13D [0001103804]
SC 13G [0001103804]
Form 13D/13G Filer Form 13D/13G Subject Filed
Viking Global Investors LP Fortive Corp [2025-07-24]
Viking Global Investors LP Primo Brands Corp [2025-06-18]
Viking Global Investors LP Acuren Corp [2025-05-15]
Viking Global Investors LP Regal Rexnord Corp [2025-04-18]
Viking Global Investors LP Sionna Therapeutics Inc [2025-02-14]
Viking Global Investors LP BioMarin Pharmaceutical Inc [2024-09-30]
Viking Global Investors LP Longboard Pharmaceuticals Inc [2024-07-15]
Viking Global Investors LP Inhibrx Biosciences Inc [2024-06-07]
Viking Global Investors LP Oric Pharmaceuticals Inc [2024-01-30]
Viking Global Investors LP Standard Biotools Inc [2024-01-09]
View All
Form 3/4/5 Subject 2011 - 2025
Viking Global Opportunities Portfolio GP LLC
Viking Global Opportunities Illiquid Investments Sub-Master
Viking Global Opportunities Parent GP LLC
Halvorsen Ole Andreas
Ott David C.
Shabet Rose Sharon
Viking Global Opportunities GP LLC
BridgeBio Pharma, Inc.
Viking Global Investors LP
Acuren Corp
Viking Global Equities Master Ltd.
APi Group Corp
Viking Global Performance LLC
Viking Global Equities II LP
Inhibrx Biosciences, Inc.
Inhibrx, Inc.
Standard Biotools Inc
Viking Global Opportunities Drawdown GP LLC
RayzeBio, Inc.
Viking Global Opportunities Drawdown (Aggregator) LP
Viking Global Opportunities Drawdown Portfolio GP LLC
4D Molecular Therapeutics, Inc.
Roivant Sciences Ltd.
Frazier Lifesciences Acquisition Corp
Rallybio Corp
Dragsa 50 LLC
Amylyx Pharmaceuticals, Inc.
Dragsa 96 LLC
Dragsa 88 LLC
PROCEPT BioRobotics Corp
Ginkgo Bioworks Holdings, Inc.
FIGS, Inc.
Viking Long Fund Master Ltd.
Viking Long Fund GP LLC
Adaptive Biotechnologies Corp
Zentalis Pharmaceuticals, Inc.
Arbutus Biopharma Corp
Sio Gene Therapies Inc.
Myovant Sciences Ltd.
Urovant Sciences Ltd.
Sundheim Daniel S.
First Data Corp
Viking Global Equities LP
VGE III Portfolio Ltd.
Editas Medicine, Inc.
Wayfair Inc.
Purcell Thomas W. JR
Comparable Firms State AUM ($B)
Sixth Street Advisers LLC
TX 80.0
Clearlake Capital Group LP
CA 79.6
Leonard Green & Partners LP
CA 75.0
Tiger Global Management LLC
NY 69.6
Coatue Management LLC
NY 69.5
Bain Capital Credit LP
MA 68.0
Centerbridge Partners LP
NY 66.4
TA Associates Management LP
MA 60.7
Sequoia Capital Operations LLC
CA 60.5
American Beacon Advisors Inc
TX 58.8
Terms | Privacy | Guide
tony@aum13f.com